Former FDA chief Scott Gottlieb: Breaking vaccine patent won't solve global shortage

The Biden administration announced last week that it supports waiving intellectual property protections for Covid-19 vaccines in order to address the global shortage. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined "Squawk Box" on Monday to discuss his thoughts on the debate.
Mon, May 10 202110:59 AM EDT